CooperSurgical

CooperSurgical, a subsidiary of The Cooper Companies, Inc. (NYSE: COO), is a dominant global force in the women's health and fertility sector with a mission to create 'a world of healthy women, babies, and families.' The company has achieved this through a strategic blend of internal R&D and targeted acquisitions, building a portfolio of over 600 products used in over 100 countries. Its strategy centers on providing clinic-ready, evidence-based technologies that enhance clinical efficiency and patient outcomes, solidifying its position as a trusted partner to healthcare providers worldwide.

A diversified portfolio of integrated technologies across fertility lab systems (culture media, time-lapse incubation, sperm selection), minimally invasive surgical devices, diagnostics, and office gynecology products, focused on clinical utility and workflow efficiency.

Competes with specialized fertility players (Vitrolife, Genea) and large medtech conglomerates (Hologic, Boston Scientific) in women's health. Its primary advantage is a comprehensive, integrated product portfolio within the niche, creating high switching costs and a differentiated value proposition as a single-source supplier.